Neil Desena is the Managing Partner at SenaHill Partners, LP, a position he has held since January 2013. Based in the United States, Neil plays a pivotal role in the firm's strategic direction and investment decisions.

In addition to his role at SenaHill, Neil serves as a Board Member at Symbiont.io since March 2015 and is an Advisory Board Member at Excision BioTherapeutics Inc. since January 2015. He is also the President of DeSena Investments, a role he has held since January 2006.

Previously, Neil was an Independent Board Member at Pico Quantitative Trading from November 2009 to July 2013. He also served as Managing Director at Goldman Sachs from October 2000 to December 2005 and was a Partner/Managing Director at Spear, Leeds & Kellogg from September 1987 to October 2000.

Neil's extensive experience in the financial sector underscores his expertise and leadership in investment banking.